Hector Abate, Pediatric Infectious Diseases Division, Hospital Humberto Notti, Mendoza, Argentina; Pablo Bonvehi, Infectious Diseases Division, Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno" (CEMIC), Buenos Aires, Argentina; Ana Ceballos, Pediatric Infectious Diseases, Sociedad Argentina de Pediatría, Córdoba, Argentina; Ralf Clemens, Global Research in Infectious Diseases (GRID), Rio de Janeiro, Brazil; Alejandro Ellis, Pediatric Infectious Diseases, Sociedad Argentina de Pediatría, Buenos Aires, Argentina; Gabriela Ensinck, Pediatric Infectious Diseases Division, Hospital de Niños "Víctor J. Vilela", Rosario, Argentina; Angela Gentile and Norberto Giglio, Epidemiology and Primary Care Division, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina; Silvia González Ayala, Universidad Nacional de La Plata, La Plata, Argentina; Renato Kfouri, Pediatric Infectious Diseases, Sociedade Brasileira de Imunizações, São Paulo, Brazil; Gabriel Oselka, Universidade de São Paulo, São Paulo, Brazil; Marco Aurélio Palazzi Sáfadi, School of Medicine, Santa Casa de São Paulo, São Paulo, Brazil; Charlotte Russ, Pediatric Infectious Diseases, Sociedad Argentina de Pediatría, Buenos Aires, Argentina; Ricardo W. Rüttimann and Daniel Stamboulian, Fighting Infectious Diseases in Emerging Countries (FIDEC), Miami, Florida, United States of America; and Carla Vizzotti, Sociedad Argentina de Infectología, Buenos Aires, Argentina.
Rev Panam Salud Publica. 2017 Jun 8;41:e76. doi: 10.26633/RPSP.2017.76.
A group of influenza experts from Argentina and Brazil got together to discuss the burden of influenza in children, review current vaccine coverage rates in both countries, analyze vaccine effectiveness, and discuss strategies to improve prevention. Active surveillance of respiratory viruses is carried out nationwide in both countries. Years 2014 and 2015 were mild influenza seasons; influenza virus type A/H3N2 prevailed, whereas type B represented less than 30% of isolates. Trivalent inactivated influenza vaccine is included in National Immunization Programs for 1) children 6 months to 2 years old in Argentina; 2) children 6 months to 5 years old in Brazil; and 3) all high-risk individuals. Coverage rates in both countries were about 80% (albeit lower for the second dose). Experts from both countries proposed the following strategies to improve prevention: 1) increase surveillance; 2) assess effectiveness and long-term safety of influenza vaccines; 3) reinforce vaccination programs in order to increase coverage rates; and 4) consider introducing more effective vaccines, such as adjuvanted trivalent vaccines. In Argentina, estimating case-fatality rates was also recommended. Other proposed actions included enhancing education of health professionals and the lay community, and better use of communication resources to raise awareness of the burden of influenza and promote vaccine uptake.
来自阿根廷和巴西的一组流感专家齐聚一堂,讨论儿童流感负担,回顾两国当前的疫苗接种率,分析疫苗效力,并探讨改善预防工作的策略。两国均在全国范围内开展呼吸道病毒的主动监测。2014年和2015年是流感温和季;甲型H3N2流感病毒占主导,而乙型流感病毒分离株不到30%。三价灭活流感疫苗被纳入国家免疫规划,用于:1)阿根廷6个月至2岁的儿童;2)巴西6个月至5岁的儿童;3)所有高危人群。两国的接种率约为80%(第二剂接种率略低)。两国专家提出了以下改善预防工作的策略:1)加强监测;2)评估流感疫苗的效力和长期安全性;3)强化疫苗接种计划以提高接种率;4)考虑引入更有效的疫苗,如佐剂三价疫苗。在阿根廷,还建议估算病死率。其他提议的行动包括加强对卫生专业人员和普通民众的教育,以及更好地利用传播资源,以提高对流感负担的认识并促进疫苗接种。